Array Biopharma, Inc. (ARRY) Posts Q3 Loss of 20c/Share
Tweet
Share
E-mailGet Alerts ARRY Hot Sheet
Price: $4.29 +2.14%
Revenue Growth %: -16.2%
Financial Fact:
Weighted average shares outstanding - diluted (in shares): 145.1M
Today's EPS Names:
ALZN, ASPU, USAU, More
Revenue Growth %: -16.2%
Financial Fact:
Weighted average shares outstanding - diluted (in shares): 145.1M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Array Biopharma, Inc. (NASDAQ: ARRY) reported Q3 EPS of ($0.20), $0.01 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $7.8 million versus the consensus estimate of $9.4 million.
For earnings history and earnings-related data on Array Biopharma, Inc. (ARRY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald’s said to plan value strategy overhaul to revive US sales growth
- Faraday Future says it regained Nasdaq compliance after equity shortfall
- F5 Positioned as Market Shaper in the Gartner Emerging Market Quadrant™ for AI Application Security
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
